Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

PRISMA flow chart. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Unadjusted cumulative incidence of stroke and all-cause mortality by type of anti-coagulant. by Simon de Lusignan (2416)

Subjects:

Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke. by Simon de Lusignan (2416)

Subjects:

Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis. by Mohamed R. Abdelraouf (21501468)

Subjects:

Mean (standard deviation) of the ratio between T and NT areas of the cross-sectional microhardness for the different anti-cariogenic solutions combining the results for pH cycling... by Flaviana Alves Dias (10439927)

Frequency of α4β7⁺ cells is significantly decreased on naïve CD4⁺ T cells of patients with UC treated with VDZ compared to untreated UC patients. by Melanie Wittner (7053818)

The risks of bias in individual studies and the overall risk of bias. by Yuan-yuan WANG (19370071)

Subjects:

Sodium levels in Canadian restaurant menu items compared to UK National Salt Reduction Initiative (NSRI) targets by UK NSRI food category. by Caroline G. Middleton (22041479)

Subjects:

Intrathecal injection of IGF2 siRNA decreases IGF2 mRNA expression in the spinal cord. by Wei-Hung Chan (11785304)

Time-varying effect of anti-coagulation regime on sub-distribution hazards for all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(a) Breast cancer incidence in female SLE cohort is significantly decreased by SLE status (OR 0.52, 95% CI 0.35, 0.74, p = 0.0036). …”

DataSheet_1_Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.docx by Taotao Liang (9944552)

“…Altogether, this study demonstrates that decreased TCF1 and BCL11B expression is significantly correlated with poor prognosis, which may be due to decreased TCF1+CD8+ T cells, impairing the effector CD8+ T cell differentiation regulated by TCF1/BCL11B.…”

Knock-down of <i>PYCR1</i> decreases proliferation of CRC cell lines. by Saif Sattar Alaqbi (12055053)